Pharmacology Terminology

Why This Matters

Pharmacology terminology is the conceptual framework you'll use to understand every drug you encounter. These terms explain why a drug works, how it moves through the body, and what determines whether it helps or harms a patient. You're being tested on your ability to connect these concepts: understanding that bioavailability, half-life, and therapeutic index all influence dosing decisions, or recognizing how agonists and antagonists produce opposite effects at the same receptor.

Master these terms and you'll be able to predict drug behavior, anticipate interactions, and make informed clinical decisions. Don't just memorize definitions. Know what principle each term illustrates and how it connects to the bigger picture of drug therapy. When you see a question about why one drug requires more frequent dosing than another, you should immediately think half-life and clearance. That's the level of understanding that separates strong exam performance from struggling through recall.

---

The Journey of a Drug: Pharmacokinetics (ADME)

Pharmacokinetics answers the question: "What does the body do to the drug?" These four processes work together as a system to determine how much drug reaches its target and how long it stays active.

Pharmacokinetics

• The study of ADME processes: absorption, distribution, metabolism, and excretion
• Determines onset, intensity, and duration of drug effects based on how quickly and completely each process occurs
• Clinical applications include calculating dosing intervals, adjusting doses for organ impairment, and predicting drug accumulation

Absorption

• Entry into the bloodstream from the administration site. This is where bioavailability begins.
• Route of administration matters: IV bypasses absorption entirely (drug goes straight into the blood), while oral drugs must cross the GI tract and survive first-pass metabolism before reaching systemic circulation
• Factors affecting absorption include drug formulation (tablet vs. liquid vs. extended-release), pH at the absorption site, blood flow to that area, and the presence of food or other substances

Distribution

• Dispersion throughout body compartments. After reaching the blood, the drug travels into tissues where it can act.
• Protein binding is critical: only the unbound (free) fraction of a drug can cross cell membranes and produce effects. A drug that is 95% protein-bound has only 5% available to work at any given moment.
• Volume of distribution ($V_d$) is a calculated value indicating whether a drug stays mostly in the blood (low $V_d$) or spreads widely into tissues (high $V_d$)

Metabolism

• Biotransformation primarily in the liver. Enzymes, especially the cytochrome P450 (CYP450) family, chemically modify drugs to make them easier to excrete.
• First-pass metabolism occurs when oral drugs are absorbed from the GI tract and pass through the liver before reaching systemic circulation. This can dramatically reduce bioavailability.
• Active metabolites may be more potent, less potent, or even toxic compared to the parent drug. Some drugs (called prodrugs) are actually inactive until the liver converts them into their active form.

Excretion

• Elimination from the body, primarily via the kidneys (urine) but also through bile, lungs, and sweat
• Renal function directly impacts clearance. Impaired kidneys mean slower elimination and potential drug accumulation leading to toxicity. This is why kidney function tests (like creatinine clearance) guide dosing for many drugs.
• Enterohepatic recirculation can prolong drug effects: some drugs excreted in bile get reabsorbed from the intestine back into the bloodstream, effectively recycling the drug

---

Measuring Drug Behavior: Key Parameters

These quantitative measures help clinicians make precise dosing decisions. Understanding them allows you to predict how a drug will behave in the body and adjust therapy accordingly.

Half-life

• Time for plasma concentration to decrease by 50%, typically written as $t_{1/2}$
• Determines dosing frequency: drugs with short half-lives need more frequent dosing to maintain therapeutic levels. A drug with a 4-hour half-life might be dosed every 4-6 hours, while one with a 24-hour half-life can be given once daily.
• Steady state is reached after approximately 4-5 half-lives of consistent dosing. At steady state, the amount of drug entering the body equals the amount being eliminated.

Bioavailability

• Fraction of an administered dose that reaches systemic circulation in active form, expressed as a percentage or decimal ($F$)
• IV administration = 100% bioavailability by definition, since the drug enters the bloodstream directly. Oral bioavailability varies widely due to incomplete absorption and first-pass metabolism.
• Formulation differences can affect bioavailability, which is why generic drugs must demonstrate bioequivalence to the brand-name version before approval

Therapeutic Index

• Ratio of the toxic dose to the effective dose: $TI = \frac{TD_{50}}{ED_{50}}$
• Higher TI = safer drug with more room for dosing error. Low TI drugs (like warfarin, lithium, and digoxin) require careful monitoring because the effective dose is dangerously close to the toxic dose.
• Narrow therapeutic index drugs are high-yield exam topics. Small dose changes can tip a patient from treatment failure into toxicity, which is why these drugs often require blood level monitoring.

---

How Drugs Produce Effects: Pharmacodynamics

Pharmacodynamics answers the question: "What does the drug do to the body?" This involves receptor interactions, signal transduction, and the relationship between dose and response.

Pharmacodynamics

• Study of drug mechanisms and effects: how drugs interact with biological targets to produce therapeutic outcomes
• Receptor theory is central: most drugs work by binding to specific protein targets on or inside cells
• Encompasses potency, efficacy, and selectivity, all of which are used to compare drugs within a class

Receptor

• Protein targets that recognize and respond to ligands (drugs, hormones, neurotransmitters)
• Major receptor types differ in how fast they signal:
  • Ion channels — fastest (milliseconds)
  • G-protein coupled receptors (GPCRs) — moderate (seconds)
  • Enzyme-linked receptors — slower (minutes)
  • Nuclear/intracellular receptors — slowest (hours, because they alter gene expression)
• Receptor density and sensitivity can change with chronic drug exposure, explaining phenomena like tolerance and sensitization

Agonist

• Binds to and activates a receptor, producing a biological response that mimics the body's own signaling molecules (endogenous ligands)
• Full agonists produce the maximal possible response at that receptor. Partial agonists produce a submaximal response even when every receptor is occupied, and they can actually block full agonists from binding.
• Examples: morphine (full agonist at opioid receptors), albuterol ($\beta_2$-adrenergic agonist used for asthma), insulin (insulin receptor agonist)

Antagonist

• Binds to a receptor but does not activate it. By occupying the binding site, it blocks agonists from producing their effect.
• Competitive antagonists compete with agonists for the same binding site and can be overcome by increasing the agonist concentration. Non-competitive antagonists bind at a different site or irreversibly, and increasing the agonist dose cannot fully overcome their blockade.
• Examples: naloxone (competitive antagonist that reverses opioid overdose), propranolol (blocks $\beta$-adrenergic receptors), atropine (blocks muscarinic acetylcholine receptors)

Dose-Response Curve

• Graphical representation of the relationship between drug concentration (x-axis, usually logarithmic) and the magnitude of effect (y-axis)
• Key features to identify: threshold dose (minimum dose to produce any effect), $ED_{50}$ (dose producing 50% of maximal effect), and maximal efficacy (the ceiling of the curve)
• Comparing two curves tells you about relative potency (a leftward shift means the drug is more potent, needing a lower dose) and efficacy (a higher plateau means the drug produces a greater maximum effect)

---

Drug Effects: Intended and Unintended

Not all drug effects are therapeutic. Understanding the spectrum from predictable side effects to dangerous adverse reactions helps you anticipate and manage clinical problems.

Side Effect

• Unintended effect occurring at normal therapeutic doses, often predictable based on the drug's mechanism of action
• May be tolerable or even useful: diphenhydramine (an antihistamine) causes drowsiness as a side effect, which is why it's also marketed as a sleep aid
• Severity ranges from minor annoyances (dry mouth, mild nausea) to effects significant enough to warrant stopping the drug

Adverse Drug Reaction (ADR)

• Harmful, unintended response at normal doses, more serious than typical side effects
• Type A reactions are dose-dependent and predictable from the drug's known pharmacology (e.g., bleeding from too much warfarin). Type B reactions are idiosyncratic and unpredictable, often involving allergic or genetic mechanisms (e.g., penicillin anaphylaxis).
• Reporting ADRs through systems like the FDA's MedWatch contributes to post-marketing surveillance and helps identify rare reactions not caught in clinical trials

Drug Interaction

• One drug altering the effect of another, which can occur at the pharmacokinetic or pharmacodynamic level
• Pharmacokinetic interactions: one drug changes the absorption, metabolism, or excretion of another. A classic example is grapefruit juice inhibiting the CYP3A4 enzyme, which slows metabolism of certain drugs and raises their blood levels.
• Pharmacodynamic interactions: two drugs acting on similar pathways produce combined effects that may be additive (1+1=2), synergistic (1+1=3), or antagonistic (1+1=0.5)

---

Chronic Drug Exposure: Adaptation and Dependence

The body doesn't passively accept ongoing drug exposure. It adapts. These concepts explain why drug effects change over time and why stopping certain drugs causes problems.

Tolerance

• Decreased response to a drug over time, requiring higher doses to achieve the same effect
• Mechanisms include receptor downregulation (fewer receptors available), increased drug metabolism (the liver gets faster at breaking it down), and physiological compensation (the body counteracts the drug's effects)
• Cross-tolerance occurs between drugs that act on the same system. For example, someone tolerant to alcohol will also show reduced response to benzodiazepines, because both enhance GABA signaling.

Dependence

• Physiological or psychological adaptation to a drug's presence, where the body now requires the drug to function normally
• Physical dependence manifests as withdrawal symptoms when the drug is stopped. Psychological dependence involves craving and compulsive drug-seeking behavior.
• Not synonymous with addiction. A patient taking chronic opioids for legitimate pain management may be physically dependent (they'll have withdrawal if the drug is stopped abruptly) without being addicted (they're not compulsively misusing the drug).

Withdrawal

• Symptoms that emerge when a drug is abruptly reduced or stopped in a dependent individual
• Withdrawal symptoms are often the opposite of the drug's effects: opioid withdrawal causes pain, diarrhea, and anxiety (the opposite of analgesia, constipation, and sedation)
• Severity varies widely, from uncomfortable (caffeine withdrawal headache) to life-threatening (seizures from abrupt alcohol or benzodiazepine withdrawal, which is why these drugs require gradual tapering)

---

Foundational Concepts

Drug

• Any substance that alters normal physiological function, used for diagnosis, treatment, prevention, or cure of disease
• Classification systems organize drugs by chemical structure, mechanism of action, or therapeutic use. You'll see all three approaches throughout your coursework.
• Drugs can be natural (derived from plants, animals, or minerals), semi-synthetic (chemically modified natural compounds), or fully synthetic (created entirely in a lab)

---

Quick Reference Table

---

Self-Check Questions

1. A patient takes an oral medication that undergoes extensive first-pass metabolism. Which two pharmacokinetic concepts explain why the effective dose might be higher than for an IV formulation?

2. Compare and contrast competitive and non-competitive antagonists. How would increasing the dose of an agonist affect each type?

3. A drug has a half-life of 6 hours. How long until steady state is reached with regular dosing, and why does this matter clinically?

4. Explain why a patient with chronic pain might exhibit both tolerance and physical dependence to opioids. How are these phenomena related but distinct?

5. If you're presented with two drugs that have different dose-response curves, what specific features would you analyze to discuss their relative potency and efficacy?